Literature DB >> 235639

Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect.

E J Simon, J M Hiller, J Groth, I Edelman.   

Abstract

Addition of sodium salts has been reported to enhance stereospecific binding of opiate antagonists while reducing binding of agonists to rat brain homogenate. We have tested, in addition to sodium and potassium, a number of organic cations. Our results support the suggestion that the ability to enhace antagonist binding is not a general characteristic of cations or high ionic strength, but a property of sodium ions. We have shown that the increase in antagonist binding results from an enhancement of binding affinity and not from unmasking of new binding sites. The reduction in etorphine binding in the presence of sodium is due to a decrease in binding affinity. This decrease is largely accounted for by an acceleration in the dissociation rate, while the greater affinity of naltrexone binding appears to be due to an increase in rate of association. Our results are consistent with the hypothesis of a conformational change in opiate binding sites in the presence of sodium, transformed sites exhibiting greater affinity for antagonists and reduced affinity for agonists. Preheating of rat brain P2 fraction at 50 degrees C results in gradual inactivation of stereospecific binding, but an increase in naltrexone binding is consistently observed after heating at 50 degrees C for 2 to 3 minutes, even at optimal concentrations of sodium.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235639

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

Review 1.  Invertebrate and vertebrate neuroimmune and autoimmunoregulatory commonalties involving opioid peptides.

Authors:  G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

2.  The effects of opioid drugs and of lithium on steroidogenesis in rat adrenal cell suspensions.

Authors:  A Gibson; M Ginsburg; M Hall; S L Hart
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

3.  Comparison of the receptor binding characteristics of opiate agonists interacting with mu- or kappa-receptors.

Authors:  H W Kosterlitz; F M Leslie
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

4.  Kinetics of opiate receptor inactivation by sulfhydryl reagents: evidence for conformational change in presence of sodium ions.

Authors:  E J Simon; J Groth
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

5.  The opiate receptors.

Authors:  E J Simon
Journal:  Neurochem Res       Date:  1976-02       Impact factor: 3.996

6.  Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP.

Authors:  A J Blume; D Lichtshtein; G Boone
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Opiate receptor: cooperativity of binding observed in brain slices.

Authors:  M E Davis; T Akera; T M Brody; L Watson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Calcium depletion of synaptosomes after morphine treatment.

Authors:  H L Cardenas; D H Ross
Journal:  Br J Pharmacol       Date:  1976-08       Impact factor: 8.739

Review 9.  Buprenorphine: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-02       Impact factor: 9.546

10.  Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.

Authors:  G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.